Developing a vaccine to prevent hepatitis C virus infections
Broadly Effective HCV Vaccine
This study is working on new vaccines for hepatitis C that can help your body build a strong defense against the virus, aiming to offer better protection than current treatments.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11015057 on NIH RePORTER |
What this research studies
This research aims to create new vaccine candidates for hepatitis C virus (HCV) that can generate strong immune responses. The approach focuses on enhancing the vaccine's ability to present key viral components that stimulate the production of broadly neutralizing antibodies, which are crucial for fighting off various strains of the virus. The research involves detailed structural analysis of HCV proteins and testing the vaccine's effectiveness in preclinical animal models. By addressing the ongoing challenge of rising HCV infections, this work seeks to provide a long-term solution beyond current antiviral treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of hepatitis C infection, including those with high exposure to the virus.
Not a fit: Patients who are already infected with hepatitis C and are seeking treatment may not benefit directly from this vaccine-focused research.
Why it matters
Potential benefit: If successful, this research could lead to an effective vaccine that significantly reduces new hepatitis C infections.
How similar studies have performed: While there have been various attempts to develop HCV vaccines, this approach is innovative and aims to address challenges that previous efforts have faced.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Law, Mansun — Scripps Research Institute, the
- Study coordinator: Law, Mansun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.